GlassScriptPhysician profile
Mario Flores
NPI 1184088841
$5,503.38
in general payments reported to CMS, 2019-2025
25 companies · $561 in 2025
The $561 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $863 · 2022: $351 · 2023: $3,174 · 2024: $555 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,219 · Travel and Lodging: $2,038 · Education: $33.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,218.56 |
| Travel and Lodging | $2,037.83 |
| Education | $33.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,159.20 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $408.53 | 2023 | Proclaim |
| Nevro Corp. | $323.68 | 2021-2024 | Senza |
| Foundation Fusion Solutions, LLC | $269.09 | 2024-2025 | |
| Medtronic, INC. | $177.15 | 2021 | |
| Curonix LLC | $176.45 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $151.57 | 2025 | Sprint Pns System |
| Vertos Medical, INC. | $137.46 | 2023-2024 | Mild Device Kit |
| Si-Bone, INC. | $107.68 | 2021-2024 | |
| Abbvie INC. | $70.95 | 2024-2025 | |
| Stryker Corporation | $67.15 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $60.80 | 2024-2025 | Belbuca |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.69 | 2021-2022 | |
| Zimvie INC. | $43.97 | 2022 | |
| Saluda Medical Americas, INC. | $42.56 | 2025 | Evoke |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tonix Medicines, INC. | $39.56 | 2025 | Tonmya |
| Biodelivery Sciences International, INC. | $36.76 | 2021 | |
| Tersera Therapeutics LLC | $34.49 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.30 | 2022 | |
| Allergan, INC. | $25.57 | 2021 | |
| Spinal Simplicity, LLC | $24.20 | 2025 | Ha Minuteman G3-R |
| Averitas Pharma INC. | $21.27 | 2024 | Qutenza |
| Avanos Medical | $19.77 | 2024 | Coolief* Cooled Radiofrequency |
| Bayer Healthcare Pharmaceuticals INC. | $16.18 | 2022 | |
| Bioventus LLC | $14.35 | 2023 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.